Comparative efficacy of low dose, daily versus alternate day plasma exchange in severe myasthenia gravis: A randomised trial

Journal of Neurology

Volumn 254, Issue 8, 2007, Pages 989-995

  Trikha, Isha ^a   Singh, Sumit ^a   Goyal, Vinay ^a   Shukla, Garima ^a   Bhasin, Rama ^a   Behari, Madhuri ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Alternate day; Daily; Myasthenia; Plasma; Schedule; Score

Indexed keywords

AZATHIOPRINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN; STEROID;

ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; HYPOTENSION; MALE; MYASTHENIA GRAVIS; NASOGASTRIC TUBE; PLASMA; PLASMAPHERESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REVIEW; STATISTICAL SIGNIFICANCE; TUBE REMOVAL;

ADULT; DRUG ADMINISTRATION SCHEDULE; EVALUATION STUDIES AS TOPIC; FEMALE; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PLASMA EXCHANGE; PLASMAPHERESIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 34548396337     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0235-7     Document Type: Review

References (28)

1. Seybold ME (1999) Diagnosis of myasthenia gravis. In: Engel AG (ed.) Myasthenia gravis and myasthenic disorders. Oxford University Press, New York, pp. 146-166
2. Qureshi AI Suri MF (2000) Plasma exchange for treatment of myasthenia gravis: pathophysiologic basis and clinical experience. Review. Ther Apher 4(4):280-6
3. Keesey JC (2002) Crisis in Mysthenia Gravis: an historical perspective Muscle Nerve (26):1-3
4. Newsom-Davis J, Vincent A, Hawkey C, Pinching AJ, Ward CD, Wilson SG, (1978) Plasmapheresis for myasthenic gravis. N Engl J Med 298:456-457
5. Antozzi C, Gemma M, Berta E, Confalonieri P, Peluchetti D, Regi B, et al. (1991) A short plasma exchange protocol is effective in severe myasthenia gravis. J Neurol 238:103-107
6. Dau PC (1981) Response to plasmapheresis and immunosuppressive drug therapy in sixty myasthenia gravis patients. Ann NY Acad Sci 377:700-708
7. Kornfeld P, Ambiender EP, Binder AN, Goldberg J, Mitiag T, Papatestas AE, et.al. (1981). Plasmapheresis in refractory generalized myasthenia gravis. Arch Neurol 38:478-481
8. The utility of therapeutic plasmapheresis for neurological disorders. NIH Consensus development. (1986) JAMA 256(10):1333-1337
9. Assessment of plasmapheresis report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology (1996). Neurology 47:840-843
10. Pinching AJ, Newsom-Davis J, Peters DK (1976). Remission of myasthenia gravis following plasma exchange. Lancet 2:1373-1376
11. Gajdos P, Chevret S, Toyka K (2002). Plasma exchange for myasthenia gravis. Cochrane Database Syst Rev (4):CD002275
12. d'Empaire G, Hoaglin DC, Perlo VP, Pontoppidan H (1985). Efficacy of prethymectomy plasma exchange on postoperative respiratory function in myasthenia gravis. J Thorac Cardiovasc Surg 89:592-596
13. Gracey DR, Divertie MB, Howard FM Jr, Payne WS (1984). Postoperative respiratory care after transternal thymectomy in myasthenia gravis. A 3 year experience in 53 patients. Chest 86:67-71
14. Spence PA, Katz M, Morin JE (1984) Role of plasmapheresis in preparing myasthenic patients for thymectomy, initial results. Can J Surg 27:303-305
15. Yeh JH, Chiu HC (1999). Plasmapheresis in myasthenia gravis: A comparative study of daily versus alternately daily schedule. Acta Neuro Scand 90:147-151
16. Yeh JH, Chiu HC (1999). Double filtration plasmapheresis in myasthenia gravis-analysis of clinical efficacy and prognostic parameters. Acta Neurol Scand 5:305-9
17. Yeh JH, Chiu HC (2000) Comparison between double filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis. J Neurol 247:51-513
18. Panda S, Goyal V, Singh S, Srivastav T, Behari M (2004) Myasthenic crisis - a retrospective study. Neurol India 4:453-6
19. Fornasari PM, Riva G, Cosi V, Lombardi M, Piccolo G (1985) Short and long-term clinical effects of plasma exchange in 33 cases of myasthenia gravis. Int J Artif Organs 8:159-162
20. Seybold ME (1987) Plasmapheresis in myasthenia gravis. Ann NY Acad Sci 505:584-587
21. Plasmapheresis, acute Guillain Barre' Syndrome. The Guillain Barre' Syndrome Study Group (1985). Neurology 35:1096-1104
22. Mantegazza R, Bruzzone E, Borroni V, Cornelio F, Marconi M, Peluchetti D, Reji B, et.al. (1987) Single donor plasma in therapeutic plasma exchange for myasthenia gravis. Int J Artif Organs 5:315-18
23. Gogovska L, Ljapcev R, Grcevska L, Polenakovic M, Popovska M, Stojkovski L (2003). Plasma exchange in the treatment of myasthenia gravis associated with thymoma. Int J Artif.organs 26:170-3
24. Gajdos P, Chevret S, Chastang C, Clair B, Tranchant C (1997)Clinical trial of plasma exchange and high dose intravenous immunoglobulin in myasthenic gravis. Ann Neuro 41:789-796
25. Gajdos P, Chevret S, Clair B (1998) Plasma exchange and intravenous immunoglobulin in autoimmune myasthenia gravis. Ann NY Acad Sci 841;720
26. Roneger J, Rornborg M, Hermansen I, Vorstrup S (2001) Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis. Artif Organs 12:967-73
27. Chiu HC, Chen WH, Yeh JH (2000) The six years experience of plasmapheresis in patients with myasthenic gravis. Ther Apher 4:291-5.19
28. Rodnitzky RL, Goeken JA (1982). Complications of plasma exchange in neurological patients. Arch Neurol 39:350-54